Researchers at Helmholtz Munich and the Technical University of Munich (TUM) have developed Nicheformer, the first ...

QIAGEN today announced it has entered into a definitive agreement to fully acquire Parse Biosciences, a leading provider of scalable, instrument-free solutions for single-cell research. The ...

Urolithin A, a natural postbiotic known to trigger mitophagy, rejuvenated key immune cell functions in healthy middle-aged ...

Countable Labs announces advanced RNA quantification module for Countable PCR to support translational, biopharma, and ...

Whole-genome sequencing (WGS) of tumor and germline can generate actionable molecular insights that can guide precision medicine efforts in salivary gland cancer (SGC), according to a new study in JCO ...

It’s a little after 6:30 on a brisk July morning in a stone hut high in the Italian Alps. A gently hissing wood fire is ...

Although heart cells and skin cells contain identical instructions for creating proteins encoded in their DNA, they're able ...

A hidden structure inside the cell is rewriting how scientists understand leukemia. Beneath the microscope, what looked like disorder turned out to ...

The acquisition, which enables Qiagen to enter the single-cell sequencing market, is expected to close in December and contribute $40 million to 2026 revenues.

The immune/tumor microenvironment significantly influences cancer progression and the efficacy of immunotherapeutic ...